Guidance Highlights Preclinical Testing Issues For Combination Products
This article was originally published in The Gray Sheet
Executive Summary
A new guidance document from FDA discusses the types of scientific and technical data that may be needed to establish the safety and efficacy of novel combination products
You may also be interested in...
Early FDA/Sponsor Meetings Expedite Novel Product Reviews In Some Cases
Multiple review cycles for emerging technologies would be reduced, but not entirely eliminated, if industry and FDA were to meet earlier in the product development process, the agency finds
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.